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Propositions (stellingen) 
accompanying the thesis 
Caging ruthenium complexes with non-toxic ligands for 
photoactivated chemotherapy 
 
1. In PACT, the caging part (being either the ligand(s) or the metal) must 
always be tested for its cytotoxicity. 
B. S. Howerton et al., J. Am. Chem. Soc., 2012, 134, 8324-8327; D. F. Azar et 
al., Dalton Trans., 2017, 46, 11529-11532; This thesis, Chapter 3 
2. Strain elongates a ruthenium-thioether bond, but not a stronger 
ruthenium-carboxylate bond. 
This thesis, Chapter 2 and Chapter 4 
3. Non-selective photosubstitution of two different ligands in tris-
bidentate complexes is rarely reported in literature. Probably not 
because it is a rare phenomenon, but because it is difficult to explain. 
This thesis, Chapter 4 
4. DFT is a very accurate tool to predict the experimentally obtained 
complex in potential mixtures containing up to sixteen isomers. 
This thesis, Chapter 6 
5. The lack of a standard irradiation setup in PACT research makes the 
comparison of the results obtained in different laboratories very 
difficult. 
S. L. Hopkins et al., Photochem. Photobiol. Sci., 2016, 15, 644-653. 
6. From a chemical point of view it makes sense to compare 
(photo)cytotoxicity experiments under hypoxic vs. normoxic conditions 
to prove an oxygen-independent mode of action. However, this is not 
true from a biological point of view. 
This thesis, Chapter 7 
7. In inorganic chemistry, predicting the outcome of a photochemical 
reaction is more complicated than predicting that of a thermal reaction. 
This thesis, Chapter 2 and Chapter 4 
8. DNA interaction tests are of limited usefulness when the localization of 
the anticancer metallodrug is unknown. 
9. Multidisciplinarity has its drawbacks: one might know a little of many 
things and be an expert on nothing. 
10. It will remain uncertain if the personal and professional growth in the 
last four years would have occurred doing anything other than a PhD. 
 
Jordi-Amat Cuello-Garibo 
Leiden, November 2017 
 
 
